Single User License
INR 19326
Site License
INR 38652
Corporate User License
INR 57978

Service Tax Additional

select a format
Price

Single User License
USD 300
Site License
USD 600
Corporate User License
USD 900

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Esperion Therapeutics, Inc. (ESPR)-Financial and Strategic SWOT Analysis Review

Esperion Therapeutics, Inc. (ESPR)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH185154FSA
  • |
  • Pages: 25
  • |
  • October 2016
  • |
  • |
  Request for Sample Report

Executive Summary

Esperion Therapeutics, Inc. (Esperion) is a pharmaceutical company that develops and commercializes oral, low-density lipoprotein cholesterol (LDL-C) therapies which are used for the treatment of patients with elevated LDL-C. The company's lead product candidate, Bempedoic acid((ETC-1002), an inhibitor of ATP Citrate Lyase (ACL), an enzyme on the cholesterol biosynthesis pathway which is designed to lower elevated levels of LDL-C. It reduces cholesterol biosynthesis, decreases intracellular cholesterol and up-regulates LDL-receptors, which results in increased LDL-C clearance and reduced plasma levels of LDL-C. ETC-1002 is in Phase III clinical trials. Its early-stage product candidates, ESP41091 and ApoA-1, are intended for the treatment of Type 2 diabetes, obesity and others. Esperion is headquartered in Ann Arbor, Michigan, the US.

Esperion Therapeutics, Inc. Key Recent Developments

Aug 04, 2016: Esperion Therapeutics Reports Second Quarter 2016 Financial Results

May 04, 2016: Esperion Therapeutics Reports First Quarter 2016 Financial Results

Feb 25, 2016: Esperion Therapeutics Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter and Full Year 2015 Financial Results

Nov 05, 2015: Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Third Quarter 2015 Financial Results

Aug 06, 2015: Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Second Quarter 2015 Financial Results

This comprehensive SWOT profile of Esperion Therapeutics, Inc. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Esperion Therapeutics, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Section 1-About the Company

Esperion Therapeutics, Inc.-Key Information

Esperion Therapeutics, Inc.-Overview

Esperion Therapeutics, Inc.-Key Employees

Esperion Therapeutics, Inc.-Key Employee Biographies

Esperion Therapeutics, Inc.-Key Operational Heads

Esperion Therapeutics, Inc.-Major Products and Services

Esperion Therapeutics, Inc.-History

Esperion Therapeutics, Inc.-Company Statement

Esperion Therapeutics, Inc.-Locations And Subsidiaries

Esperion Therapeutics, Inc.-Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Esperion Therapeutics, Inc.-Business Description

Esperion Therapeutics, Inc.-Corporate Strategy

Esperion Therapeutics, Inc.-SWOT Analysis

SWOT Analysis-Overview

Esperion Therapeutics, Inc.-Strengths

Esperion Therapeutics, Inc.-Weaknesses

Esperion Therapeutics, Inc.-Opportunities

Esperion Therapeutics, Inc.-Threats

Esperion Therapeutics, Inc.-Key Competitors

Section 3-Company Financial Performance Charts

Esperion Therapeutics, Inc.-Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Appendix

Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Figures

Esperion Therapeutics, Inc., Performance Chart

Esperion Therapeutics, Inc., Ratio Charts

List of Tables

Esperion Therapeutics, Inc., Key Information

Esperion Therapeutics, Inc., Key Ratios

Esperion Therapeutics, Inc., Share Data

Esperion Therapeutics, Inc., Major Products and Services

Esperion Therapeutics, Inc., History

Esperion Therapeutics, Inc., Key Employees

Esperion Therapeutics, Inc., Key Employee Biographies

Esperion Therapeutics, Inc., Key Operational Heads

Esperion Therapeutics, Inc., Other Locations

Esperion Therapeutics, Inc., Subsidiaries

Esperion Therapeutics, Inc., Key Manufacturing facilities

Esperion Therapeutics, Inc., Key Competitors

Esperion Therapeutics, Inc., SWOT Analysis

Esperion Therapeutics, Inc., Ratios based on current share price

Esperion Therapeutics, Inc., Annual Ratios

Esperion Therapeutics, Inc., Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Esperion Therapeutics, Inc., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com